RxDoctor Payments Data

David Duvernois, PA

Physician Assistant · Charlotte, NCNPI 1205066453

Payments from drug & device makers

$1,467in general payments, 2019–2025

Across 71 payments — averaging $20.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$336
  • AbbVie$197
  • Teleflex LLC$146
  • Endo Pharmaceuticals Inc.$96
  • Dendreon Pharmaceuticals LLC$90
  • Urovant Sciences Inc$82
  • plus $521 from 17 others

What the payments were for

  • Food & beverage$1,467100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,467 in reported general payments places this provider in the 75th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$93,819
Medicare patients
528
Services billed
2,213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron177$145,396
GemtesaVibegron110$92,383
Tamsulosin Hcl649$9,046
Desmopressin Acetate61$5,870
Finasteride397$5,263
Methenamine Hippurate54$4,847
Estradiol46$3,464
Trospium Chloride58$3,460
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst59$3,040
Cephalexin191$2,868
Testosterone Cypionate65$2,584
Solifenacin Succinate92$2,401
Oxybutynin Chloride ErOxybutynin Chloride133$2,327
Testosterone11$2,302
Potassium Citrate ErPotassium Citrate21$2,054

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$33$145,396177 claims
Sumitomo Pharma America, Inc.Gemtesa$336$92,383110 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →